Michael John Tomsicek - Net Worth and Insider Trading
Michael John Tomsicek Net Worth
The estimated net worth of Michael John Tomsicek is at least $124,396 dollars as of 2024-04-30. Michael John Tomsicek is the CFO of CRISPR Therapeutics AG and owns about 1,891 shares of CRISPR Therapeutics AG (CRSP) stock worth over $100,696. Michael John Tomsicek is also the Director of Milestone Pharmaceuticals Inc and owns about 15,000 shares of Milestone Pharmaceuticals Inc (MIST) stock worth over $23,700. Details can be seen in Michael John Tomsicek's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael John Tomsicek has not made any transactions after 2022-10-19 and currently still holds the listed stock(s).
Transaction Summary of Michael John Tomsicek
Michael John Tomsicek Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael John Tomsicek owns 4 companies in total, including CRISPR Therapeutics AG (CRSP) , Milestone Pharmaceuticals Inc (MIST) , and Abiomed Inc (ABMD) among others .
Click here to see the complete history of Michael John Tomsicek’s form 4 insider trades.
Insider Ownership Summary of Michael John Tomsicek
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2021-08-06 | Chief Financial Officer |
| MIST | Milestone Pharmaceuticals Inc | 2022-10-19 | director |
| ABMD | Abiomed Inc | 2015-07-15 | Vice President & CFO |
| ACRV | Acrivon Therapeutics Inc | 2022-11-09 | director |
Michael John Tomsicek Latest Holdings Summary
Michael John Tomsicek currently owns a total of 2 stocks. Among these stocks, Michael John Tomsicek owns 1,891 shares of CRISPR Therapeutics AG (CRSP) as of August 6, 2021, with a value of $100,696 and a weighting of 80.95%. Michael John Tomsicek also owns 15,000 shares of Milestone Pharmaceuticals Inc (MIST) as of October 19, 2022, with a value of $23,700 and a weighting of 19.05%.
Latest Holdings of Michael John Tomsicek
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2021-08-06 | 1,891 | 53.25 | 100,696 |
| MIST | Milestone Pharmaceuticals Inc | 2022-10-19 | 15,000 | 1.58 | 23,700 |
Holding Weightings of Michael John Tomsicek
Michael John Tomsicek Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael John Tomsicek has made a total of 3 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 25,000 shares on August 6, 2021, which brought Michael John Tomsicek around $3 Million.
According to the SEC Form 4 filings, Michael John Tomsicek has made a total of 1 transactions in Milestone Pharmaceuticals Inc (MIST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Milestone Pharmaceuticals Inc is the acquisition of 15,000 shares on October 19, 2022, which cost Michael John Tomsicek around $79,800.
Insider Trading History of Michael John Tomsicek
- 1
Michael John Tomsicek Trading Performance
GuruFocus tracks the stock performance after each of Michael John Tomsicek's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael John Tomsicek is -24.4%. GuruFocus also compares Michael John Tomsicek's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael John Tomsicek within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael John Tomsicek's insider trading performs compared to the benchmark.
Performance of Michael John Tomsicek
Average Return
-44.56%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.86 | -24.4 | -22.78 | -44.56 | ||
| Relative Return to S&P 500(%) | -15.17 | -29.91 | -35.21 | -60.33 |
Michael John Tomsicek Ownership Network
Ownership Network List of Michael John Tomsicek
Ownership Network Relation of Michael John Tomsicek
Michael John Tomsicek Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
Michael John Tomsicek is the Chief Financial Officer of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Business Officer Samarth Kulkarni , Chief Financial Officer Raju Prasad , and General Counsel and Secretary James R. Kasinger .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, Michael John Tomsicek made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 325,337 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .
In summary, during the past 3 months, insiders sold 89,721 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 89,721 shares. During the past 18 months, 334,721 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 334,721 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
Michael John Tomsicek Mailing Address
Above is the net worth, insider trading, and ownership report for Michael John Tomsicek. You might contact Michael John Tomsicek via mailing address: 28 Overlook Drive, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
